La Gamba, F. and Jacobs, T. and Geys, H. and Jaki, T. and Serroyen, J. and Ursino, M. and Russu, A. and Faes, C. (2019) Bayesian sequential integration within a preclinical pharmacokinetic and pharmacodynamic modeling framework:Lessons learned. Pharmaceutical Statistics, 18 (4). pp. 486-506. ISSN 1539-1604
Paper2_181019.pdf - Accepted Version
Available under License Creative Commons Attribution-NonCommercial.
Download (4MB)
Abstract
The present manuscript aims to discuss the implications of sequential knowledge integration of small preclinical trials in a Bayesian pharmacokinetic and pharmacodynamic (PK-PD) framework. While, at first sight, a Bayesian PK-PD framework seems to be a natural framework to allow for sequential knowledge integration, the scope of this paper is to highlight some often-overlooked challenges while at the same time providing some guidances in the many and overwhelming choices that need to be made. Challenges as well as opportunities will be discussed that are related to the impact of (1) the prior specification, (2) the choice of random effects, (3) the type of sequential integration method. In addition, it will be shown how the success of a sequential integration strategy is highly dependent on a carefully chosen experimental design when small trials are analyzed.